SCHEMBL20094641

SCHEMBL20094641

C[C@H]1CC[C@H](O)[C@H](CCCN(CCCCCC(=O)ON2C(=O)CCC2=O)CCO[C@@H]2C[C@@H](O)[C@H](O)[C@@H](CO)O2)O1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SELP P16109 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20094642 0.90 — —
SCHEMBL19860867 0.89 LGALS8 (0.33) —
SCHEMBL19860855 0.89 LGALS8 (0.33) —
SCHEMBL20094629 0.89 — —
SCHEMBL19841485 0.88 MMP13 (0.33) —
SCHEMBL20094585 0.88 PRKCA (0.31) —
SCHEMBL19860841 0.87 — —
SCHEMBL19841507 0.87 MMP13 (0.33) —
SCHEMBL19841486 0.84 — —
SCHEMBL20094766 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180110863-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180110863-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES GPR119, INSR, IRS1 SELP 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback